NCT05895071

Brief Summary

ABSTRACT Objective: To study the efficacy while comparing Potassium hydroxide 5% with liquid nitrogen in treatment of plane warts. Study design: Randomized-controlled trial (RCT), (Double-blind). Study setting and duration: Dept dermatology, CMH-Abbottabad, Nov-2022 / April-2023. Methodology: The sample size of 60 patients (children and adults aged 4 to 30 years) was calculated using Openepi app sample size RCT calculator, after informed consent by using non-probability consecutive sampling technique. Patients randomly assigned into two groups i.e. In group-A 30 patients were given topical 5%-potassium hydroxide solution on affected area once at night upto 4 weeks and in group-B 30 patients treated with cotton bud method of cryotherapy with liquid nitrogen once every two weeks. Patients were reassessed at every two weeks and final assessment was done at 12th week whereas followed up for 3 months to monitor recurrence. Demographic information and frequency percentages were calculated for qualitative variables by using SPSS26. To determine statistical significance taking p-value \<0.05 as significant, and χ2-square test was used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Nov 2022

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

May 16, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

June 8, 2023

Completed
Last Updated

June 8, 2023

Status Verified

May 1, 2023

Enrollment Period

6 months

First QC Date

May 16, 2023

Last Update Submit

May 30, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Comparative Efficacy of topical 5% Potassium hydroxide and liquid nitrogen in the treatment of plane warts

    Decrease in number or size of warts

    12 weeks

Study Arms (2)

Group A Topical 5% potassium hydroxide

ACTIVE COMPARATOR

In group-A 30 patients were given topical 5%-potassium hydroxide solution on affected area once at night upto 4 weeks

Drug: 5%potassium hydroxide

Group B Liquid nitrogen

ACTIVE COMPARATOR

in group-B 30 patients treated with cotton bud method of cryotherapy with liquid nitrogen once every two weeks. Patients were reassessed at every two weeks and final assessment was done at 12th week.

Drug: Liquid nitrogen

Interventions

. In group-A 30 patients were given topical 5% potassium hydroxide solution on affected area once at night for upto 4 weeks

Group A Topical 5% potassium hydroxide

in group-B 30 patients treated with cotton bud method of cryotherapy with liquid nitrogen once every two weeks. Patients were reassessed at every two weeks. The treatment carried out upto 12 weeks or until complete recovery from warts.

Group B Liquid nitrogen

Eligibility Criteria

Age4 Years - 30 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 4-30 years
  • Both males and females
  • Greater than 3 number of warts

You may not qualify if:

  • Pregnancy
  • Breast feeding
  • Those who are taking immunosupressive drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sana aslam

Abbottabad, Khyber Pakhtun Khwaa, 22010, Pakistan

Location

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

May 16, 2023

First Posted

June 8, 2023

Study Start

November 1, 2022

Primary Completion

April 30, 2023

Study Completion

April 30, 2023

Last Updated

June 8, 2023

Record last verified: 2023-05

Locations